Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-05-02 Sale | 2024-05-03 3:23 pm | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 354 | $43.66 | $15,456 | 48,431 (Direct) | View |
2024-04-18 Sale | 2024-04-19 4:35 pm | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 142 | $44.1 | $6,262 | 48,785 (Direct) | View |
2024-03-01 Sale | 2024-03-05 8:10 pm | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 1,238 | $53.76 | $66,555 | 85,478 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-08-13 Option Award | 2024-08-14 5:10 pm | N/A N/A | ABEONA THERAPEUTICS INC. | ABEO | Crombez Eric Director | 11,044 | $0 | 11,044 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 8:10 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 55,951 | $0 | 85,478 (Direct) | View |
2023-09-27 Option Award | 2023-09-29 2:15 pm | N/A 2027-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 2,351 | $0 | 32,863 (Direct) | View |
2023-05-01 Option Award | 2023-05-02 6:18 pm | N/A 2033-05-01 | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 13,020 | $0 | 38,874 (Direct) | View |
Ownership | 2023-05-02 6:14 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 0 | $0 | 74,844 (Direct) | View |